Beyond the GLP-1 patch, the company sells other patches aimed at energy, skin health, aging support, focus, and even mosquito protection
AstraZeneca has positioned itself to compete with other drugmakers across a number of disease states, including in lung cancer with a Tagrisso-based combo
Anti-Aging: Improves skin elasticity and reduces fine lines via antioxidant action
This makes GLP-1 receptor agonists particularly attractive for patients with obesity complicated by type 2 diabetes, establishing them as a cornerstone treatment option
Ideal Candidates GLP-1 medications are typically prescribed for individuals with a BMI of 30 or higher or those with a BMI of 27 or higher with weight-related conditions such as type 2 diabetes or hypertension
Qsymia works through central nervous system stimulation (phentermine) and neurotransmitter modulation (topiramate)